Navigation Links
Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
Date:11/7/2007

Data Presented Today at the American Heart Association Scientific Sessions

2007 in Orlando, Florida

BOCA RATON, Fla., Nov. 7 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today announced the successful completion of its Phase 2b trial of NicVAX(R) (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational vaccine being developed to treat nicotine addiction and prevent smoking relapse. The final 12-month data confirm the highly significant trends seen in the previous data at six and nine months for both smoking cessation and long-term smoking abstinence. These data were presented at 9:45 a.m., EST today at the American Heart Association (AHA) Scientific Sessions 2007 in Orlando, Florida by one of the trial's lead investigators, Dr. Stephen Rennard, Larson Professor of Medicine, University of Nebraska Medical Center.

"I believe data from this trial are very encouraging - for smokers who are trying to quit as well as for the field of smoking cessation vaccines," said Dr. Rennard. "Only a short time ago, it was difficult to find convincing evidence to link anti-nicotine antibody with smoking cessation. This double- blind, placebo-controlled trial has demonstrated a clinical proof of concept. The data show there is a correlation between antibody level and the ability of patients to quit smoking and remain abstinent over long periods of time. This development is key for the field of smoking cessation research and could have a significant impact on how we treat patients with nicotine addiction."

NicVAX(R) Phase 2b Trial: Key Findings in Final 12 Month Data Set

Optimal NicVAX(R) Dose and Schedule Identified for Smoking Cessation a
'/>"/>

SOURCE Nabi Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- Building on the momentum of the first quarter of 2015, ... systems, has announced aggressive plans to expand its Medicaid Home ... business models. The first quarter addition of new ... and Louisiana is a ... statewide coverage in each state. This brings the total to ...
(Date:3/30/2015)... 30, 2015 Perrigo Company plc (NYSE: ... Affordable Healthcare Products®," today announced that it has completed ... in a cash and equity transaction valued at approximately ... in debt. Sellers are Marc Coucke , Waterland ...   "The combination of Perrigo ...
(Date:3/30/2015)... , March 30, 2015  Caris Life Sciences® ... drugs targeting specific pathways may have potentially significant benefit ... The study results were highlighted today in an oral ... Gynecologic Oncology (SGO) 2015 Annual Meeting on Women,s Cancer ... This study is one of four presented at the ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4
(Date:3/31/2015)... The KIND LED K5 grow lights utilize a ... These large yields are due to the KIND LED 3 amd ... K5 grow lights use a proprietary 12 band spectrum that runs ... circuit boards that are the backbone of the KIND LED lighting ... immense. The KIND LED K5 grow lights use about half of ...
(Date:3/31/2015)... Effective April, 1 2015, Plano ... practice with North Texas Obstetrics & Gynecology Associates. This ... approach to women’s healthcare. With 17 years of experience ... this move will not interrupt the care of existing ... his practice to new patients. , Recognized as a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Homeowners and ... Drivable Grass in action and installed in ... finished installation of a display plot of Drivable Grass ... , Drivable Grass is a permeable concrete pavement system ... to asphalt and concrete pavement, Drivable Grass qualifies for ...
(Date:3/31/2015)... A new study by Health eCareers found that nearly one-third ... their greatest staffing concern this year and say hiring the ... you have them, you need to keep them. The findings ... recruiting blog series , which profiles the results of the ... high numbers and results in high costs in the industry. ...
(Date:3/31/2015)... Telemedicine technology is bringing the ... Barnes-Jewish Hospital to patients at Memorial Hospital of ... (SIH) system. , “Previously, when an expectant mother ... consultation, she had to travel two hours to ... talk with a Barnes-Jewish specialist,” says Ellyn Rosenblum, ...
Breaking Medicine News(10 mins):Health News:LED SuperNova Grow Box by SuperCloset Now Available with the KIND LED K5 Series 2Health News:Plano OBGYN Dennis Eisenberg, MD Joins North Texas Obstetrics & Gynecology Associates in Plano, Texas 2Health News:Super-Sod Recently Completed a Drivable Grass Permeable Paver Demo at their Jacksonville Store 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3
... Blood pressure problems fall 75 percent after procedure, study ... weight-loss surgery before having a baby greatly lowers the ... during pregnancy, a new study reports. , Obese ... risks for blood pressure disorders such as preeclampsia during ...
... ... OxySure has been named as a finalist in the Health category for its ... Awards recognize new companies that will have a significant impact on the environment, ... used to raise funds to support business incubation programs for technology-based entrepreneurs. ...
... over finances, study finds , TUESDAY, April 13 (HealthDay News) -- ... medical care are more likely to postpone seeking emergency care for ... these factors lead to delays in seeking care of six hours ... findings. , The study, reported in the April 14 issue of ...
... , ... Makes Gift to Endow Presidential Chair , ... La Jolla, Calif. (Vocus) April 13, 2010 -- Sanford-Burnham ... President of the Institute. In this role, she will oversee Sanford-Burnham,s day-to-day operations. Prior ...
... available in French . , Montreal, ... selected by Montral,s International Laboratory for Brain, Music and ... signal processing devices (DSP) to investigate experience-dependent brain plasticity ... change a person,s sound perception, in real time, and ...
... ... of every 6 men in the United States (1 in 3 in the African American ... cancer by registering for Little Red Door,s Unite 2 Fight Race Against Prostate Cancer. ... Indianapolis, IN (PRWEB) April 13, ...
Cached Medicine News:Health News:Weight-Loss Surgery May Ease Childbirth Risks 2Health News:OxySure Systems, Inc. Named Tech Fort Worth IMPACT Awards Finalist 2Health News:OxySure Systems, Inc. Named Tech Fort Worth IMPACT Awards Finalist 3Health News:Money Worries Delay Heart Attack Treatment 2Health News:Money Worries Delay Heart Attack Treatment 3Health News:Dr. Kristiina Vuori Promoted to President of Sanford-Burnham Medical Research Institute 2Health News:Dr. Kristiina Vuori Promoted to President of Sanford-Burnham Medical Research Institute 3Health News:Dr. Kristiina Vuori Promoted to President of Sanford-Burnham Medical Research Institute 4Health News:New research tools for BRAMS via Sonomax Technologies 2Health News:Registration Now Open for Little Red Door's Unite 2 Fight Race Against Prostate Cancer Saturday, July 10, 2010 2
Lytec Medical 2004 practice management software is designed to help you more effectively manage your accounts receivable as well as track authorizations and inventory. Lytec Medical XE provides outst...
PremierEdge™ Stab Knives - 30°....
DCR Set, Angled....
... The Leica CM3050 S ... comfort with excellent safety standards ... cryosectioning applications. The Leica CM3050 ... choice for all cryosectioning research ...
Medicine Products: